Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Angiogenesis. 2019 Jan 14;22(3):369–382. doi: 10.1007/s10456-019-09662-4

Fig. 3.

Fig. 3.

Anti-Scg3 mAb to treat OIR via intraperitoneal injection. Therapeutic agents were injected at P14. a Representative images of OIR retina. b Retinal neovascularization. c NV tufts. d branch points. Bar = 100 μm (zoom-in). n= 8 eyes (PBS), n= 13 eyes (aflibercept), n= 15 eyes (anti-Scg3 mAb). ± SEM, one-way ANOVA test.